Andrew Lo - 01 Dec 2022 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Role
Director
Signature
/s/ Tryn Stimart, attorney-in-fact
Issuer symbol
ABCL
Transactions as of
01 Dec 2022
Transactions value $
$0
Form type
4
Filing time
05 Dec 2022, 11:34:41 UTC
Previous filing
19 Sep 2022
Next filing
23 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABCL Share Option (right to buy) Award $0 +47,231 +51.7% $0.000000 138,556 01 Dec 2022 Common Shares 47,231 $13.18 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.